Annexon, Inc. (ANNX)
NASDAQ: ANNX · IEX Real-Time Price · USD
4.590
+0.140 (3.15%)
At close: Apr 25, 2024, 4:00 PM
4.720
+0.130 (2.83%)
After-hours: Apr 25, 2024, 7:44 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $482.34 million as of April 25, 2024. Its market cap has increased by 84.03% in one year.
Market Cap
482.34M
Enterprise Value
252.95M
1-Year Change
84.03%
Ranking
Category
Stock Price
$4.59
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $599.60M to $482.34M, a decrease of -19.56%. That is a compound annual growth rate of -5.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 413.20M | 3.15% |
| Apr 24, 2024 | 400.60M | 0.23% |
| Apr 23, 2024 | 399.70M | -2.32% |
| Apr 22, 2024 | 409.20M | -0.32% |
| Apr 19, 2024 | 410.50M | 2.70% |
| Apr 18, 2024 | 399.70M | -3.17% |
| Apr 17, 2024 | 412.80M | -10.36% |
| Apr 16, 2024 | 460.50M | -10.88% |
| Apr 15, 2024 | 516.70M | -4.03% |
| Apr 12, 2024 | 538.40M | -1.48% |
| Apr 11, 2024 | 546.50M | -1.62% |
| Apr 10, 2024 | 555.50M | -0.96% |
| Apr 9, 2024 | 560.90M | 2.97% |
| Apr 8, 2024 | 544.70M | -2.26% |
| Apr 5, 2024 | 557.30M | -2.98% |
| Apr 4, 2024 | 574.40M | -1.08% |
| Apr 3, 2024 | 580.70M | 0.47% |
| Apr 2, 2024 | 578.00M | -3.17% |
| Apr 1, 2024 | 596.90M | -7.53% |
| Mar 28, 2024 | 645.50M | -8.19% |
| Mar 27, 2024 | 703.10M | 13.51% |
| Mar 26, 2024 | 619.40M | 75.22% |
| Mar 25, 2024 | 353.50M | -2.35% |
| Mar 22, 2024 | 362.00M | 11.66% |
| Mar 21, 2024 | 324.20M | 3.38% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 708.47B |
| Novo Nordisk | 557.89B |
| UnitedHealth Group | 448.29B |
| Johnson & Johnson | 362.19B |
| Merck & Co. | 321.58B |
| AbbVie | 299.51B |
| AstraZeneca | 219.92B |
| Thermo Fisher | 219.44B |